To discuss the current state and future potential of contact lenses for continuous intraocular pressure monitoring in glaucoma care.
Approach:
Background: Dr. Robert N. Weinreb predicted in 2014 that contact lenses capable of continuous IOP monitoring would revolutionize glaucoma care within five years.
Current Practice: Glaucoma management often relies on infrequent IOP measurements, leading to a significant blind spot in patient care.
Research Insights: 24-hour IOP monitoring reveals clinically significant fluctuations that standard office measurements miss, impacting treatment decisions.
Technological Advances: Various sensing technologies are being researched, including theranostic contact lenses that can monitor and treat elevated IOP.
Key Findings:
Current IOP measurement practices capture only a fraction of the total time, leading to potential mismanagement of glaucoma.
Nocturnal pressure elevations and transient spikes are often missed with traditional monitoring.
Innovative contact lens designs are being developed to continuously monitor IOP and deliver medication as needed.
Interpretation:
The future of glaucoma management may involve continuous IOP monitoring and automatic treatment, moving beyond traditional measurement methods.
Limitations:
Current technologies are still experimental and have not yet received FDA approval.
Challenges include ensuring long-term safety, measurement accuracy, and validation in larger clinical trials.
Conclusion:
Advancements in contact lens technology hold promise for improving glaucoma management by continuously monitoring and responding to IOP changes.
